CGC Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Hold
773
– – 0.04% 68
2026
Q2
$195K Sell
773
-75
-9% -$16.1K 0.04% 70
2026
Q1
$184K Sell
848
-199
-19% -$44.1K 0.05% 64
2025
Q4
$239K Sell
1,047
-11
-1% -$2.51K 0.06% 56
2025
Q3
$245K Hold
1,058
– – 0.07% 54
2025
Q2
$196K Hold
1,058
– – 0.07% 62
2025
Q1
$222K Sell
1,058
-73
-6% -$14.2K 0.09% 50
2024
Q4
$201K Hold
1,131
– – 0.08% 53
2024
Q3
$223K Buy
1,131
+209
+23% +$39K 0.09% 49
2024
Q2
$158K Hold
922
– – 0.07% 53
2024
Q1
$168K Buy
922
+68
+8% +$11.7K 0.09% 51
2023
Q4
$132K Buy
854
+225
+36% +$32.8K 0.06% 69
2023
Q3
$93.7K Hold
629
– – 0.07% 64
2023
Q2
$84.7K Buy
+629
New +$92.2K 0.06% 71

Other funds holding ABBV

CGC Financial Services's ABBV Position: Q3 2026 in Review

CGC Financial Services held its AbbVie (ABBV) position steady in Q3 2026 at 773 shares worth $202K. The position accounts for 0.04% of the portfolio, ranked #68.

CGC Financial Services first reported a position in ABBV in Q2 2023 and has held it in 14 quarters since. The position peaked at $245K in Q3 2025. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • CGC Financial Services held 773 shares of AbbVie worth $202K as of Q3 2026.
  • CGC Financial Services left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.04% of CGC Financial Services's portfolio in Q3 2026, its #68 holding.
  • CGC Financial Services first reported a position in AbbVie in Q2 2023 and has held it in 14 quarters since.
  • CGC Financial Services's AbbVie position peaked at $245K in Q3 2025.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on CGC Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.